Considering the important functions of CSCs, it is interesting to explore whether therapeutic agents targeting the PI3K/mTOR signaling pathway are effective in colorectal cancer driven by CSCs harboring a somatic PIK3CA mutation. The gene discussed is MTOR; the disease is colorectal cancer.